Thalidomide and thrombosis. A meta-analysis

• Published in: Thrombosis and haemostasis Vol. 97; no. 6; p. 1031
• Main Authors: El Accaoui, Ramzi N, Shamseddeen, Wael A, Taher, Ali T
• Format: Journal Article
• Language: English
• Published: Germany 01.06.2007
• Subjects: Angiogenesis Inhibitors - adverse effects; Anticoagulants - therapeutic use; Antineoplastic Agents, Hormonal - adverse effects; Dexamethasone - adverse effects; Humans; Multiple Myeloma - drug therapy; Neoplasms - drug therapy; Platelet Aggregation Inhibitors - therapeutic use; Risk Assessment; Risk Factors; Thalidomide - adverse effects; Thromboembolism - chemically induced; Thromboembolism - prevention & control; Venous Thrombosis - chemically induced; Venous Thrombosis - prevention & control

With the increase in the number of reports and trials on the use of thalidomide as a part of the treatment of different medical conditions, particularly multiple myeloma (MM), it was observed that this drug might be associated with an increase in the risk of venous thromboembolic (VTE) events. It wa...